Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07424157 · ClinicalTrials.gov registry record
Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products
A clinical trial, sponsored by Seattle Children's Hospital.
- Recruiting
- Registry status
- 500
- Enrollment target
NCT07424157 is a clinical trial that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 500 participants.
The verdict
NCT07424157 is actively recruiting participants, sponsored by Seattle Children's Hospital.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
Study Summary
Subjects exposed to gene therapy products (GTPs) may be at risk for delayed or long-term adverse events. This is a long-term follow-up (LTFU) protocol designed to evaluate the long-term safety of Seattle Children's Therapeutics (SCTx) GTPs and incorporates in monitoring guidance from the U.S. Food and Drug Administration (FDA). Subjects will be followed for up to 15 years starting from the date of the most recent infusion of an SCTx GTP. Subjects planning to receive, or who have received, at least one infusion of an SCTx GTP will be offered participation in this LTFU study. Subjects enrolled in this study will have safety assessments and laboratory evaluations performed at scheduled intervals for each unique SCTx GTP received. No treatment is administered in this LTFU study.
Interventions
- OTHER Long term follow up in all patients who received an SCTx gene therapy product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2041-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07424157
The ClinicalTrials.gov registry entry for NCT07424157 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Long term follow up in all patients who received an SCTx gene therapy product is the first listed.
NCT07424157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07424157 about?
NCT07424157 is a clinical study titled "Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products". Subjects exposed to gene therapy products (GTPs) may be at risk for delayed or long-term adverse events. This is a long-term follow-up (LTFU) protocol designed to evaluate the long-term safety of Seattle Children's Therapeutics (SCTx) GTPs and incorporates in monitoring guidance from the U.S. Food a...
What is the current status of trial NCT07424157?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2026-06-15. Estimated completion is 2041-03-31.
What interventions are being tested in trial NCT07424157?
The interventions under investigation include: Long term follow up in all patients who received an SCTx gene therapy product (OTHER).
Who is sponsoring clinical trial NCT07424157?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.